Pro-inflammatory innate-like T cells are expanded in the blood and inflamed intestine in Crohn's Disease
暂无分享,去创建一个
A. Rosenwald | M. Lohoff | F. Berberich-Siebelt | H. Mei | A. Schulz | C. Chiarolla | M. Meir | H. Chang | S. Reu-Hofer | A. J. Romero Olmedo | H.-D. Chang | N. Schlegel | Simone Reu-Hofer | Axel R. Schulz | -. AddiJ.Romero | Olmedo | Michael Lohoff | Andreas Rosenwald | Hyun-Dong Chang | Nicolas Schlegel | Henrik | E. Mei | Andreas Rosenwald
[1] Wei Li,et al. Downregulation of TIGIT Expression in FOXP3+Regulatory T Cells in Acute Coronary Syndrome , 2022, Journal of inflammation research.
[2] K. Dhama,et al. Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders – Advances and challenges , 2022, Human vaccines & immunotherapeutics.
[3] J. Däbritz,et al. New Insights on CD8+ T Cells in Inflammatory Bowel Disease and Therapeutic Approaches , 2021, Frontiers in Immunology.
[4] Asha A. Nair,et al. BMI1 maintains the Treg epigenomic landscape to prevent inflammatory bowel disease. , 2021, The Journal of clinical investigation.
[5] P. Boor,et al. Complement activation induces excessive T cell cytotoxicity in severe COVID-19 , 2021, Cell.
[6] D. Farber. Tissues, not blood, are where immune cells function , 2021, Nature.
[7] R. Koup,et al. Acquisition of optimal TFH cell function is defined by specific molecular, positional, and TCR dynamic signatures , 2021, Proceedings of the National Academy of Sciences.
[8] Maxim N. Artyomov,et al. Single-cell analyses of Crohn’s disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions , 2021, Nature Communications.
[9] V. Niederlova,et al. CD8+ Tregs revisited: A heterogeneous population with different phenotypes and properties , 2021, European journal of immunology.
[10] J. Levitt,et al. CD8+CD161+ T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential , 2021, Frontiers in Immunology.
[11] Hyun-Dong Chang,et al. Deep phenotypical characterization of human CD3+CD56+ T cells by mass cytometry , 2020, European journal of immunology.
[12] H. Ueno,et al. Shared and distinct roles of T peripheral helper and T follicular helper cells in human diseases , 2020, Cellular & Molecular Immunology.
[13] J. Waschke,et al. Targeting desmosomal adhesion and signalling for intestinal barrier stabilization in inflammatory bowel diseases—Lessons from experimental models and patients , 2020, Acta physiologica.
[14] G. Tseng,et al. Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease. , 2020, Gastroenterology.
[15] D. Pellicci,et al. Foxp3+ Tregs from Langerhans cell histiocytosis lesions co-express CD56 and have a definitively regulatory capacity. , 2020, Clinical immunology.
[16] S. Brouard,et al. Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure. , 2020, Journal of the American Society of Nephrology : JASN.
[17] Brian D. Bennett,et al. Single-Cell Analyses Identify Dysfunctional CD16+ CD8 T Cells in Smokers , 2020, Cell reports. Medicine.
[18] M. Roncalli,et al. NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high anti-tumor activity against colorectal cancer. , 2019, JCI insight.
[19] Josef Spidlen,et al. Automated optimized parameters for T-distributed stochastic neighbor embedding improve visualization and analysis of large datasets , 2019, Nature Communications.
[20] L. Terracciano,et al. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma , 2019, Cellular and molecular gastroenterology and hepatology.
[21] Andreas Grützkau,et al. Stabilizing Antibody Cocktails for Mass Cytometry , 2019, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[22] Samuel J. S. Rubin,et al. Mass cytometry reveals systemic and local immune signatures that distinguish inflammatory bowel diseases , 2019, Nature Communications.
[23] S. Baumgart,et al. Osmium-Labeled Microspheres for Bead-Based Assays in Mass Cytometry , 2019, The Journal of Immunology.
[24] R. Rad,et al. Blimp1 Prevents Methylation of Foxp3 and Loss of Regulatory T Cell Identity at Sites of Inflammation , 2019, Cell reports.
[25] H. Mei,et al. Surface Barcoding of Live PBMC for Multiplexed Mass Cytometry. , 2019, Methods in molecular biology.
[26] D. Merkler,et al. Resident-Memory T Cells in Tissue-Restricted Immune Responses: For Better or Worse? , 2018, Front. Immunol..
[27] M. Pirooznia,et al. Human retinoic acid–regulated CD161+ regulatory T cells support wound repair in intestinal mucosa , 2018, Nature Immunology.
[28] S. Kumari,et al. Leishmania donovani mediated higher expression of CCL4 induces differential accumulation of CD4+CD56+NKT and CD8+CD56+NKT cells at infection site , 2018, Cytokine.
[29] I. Noth,et al. PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production , 2018, Science Translational Medicine.
[30] M. Kaplan,et al. Effector T Helper Cell Subsets in Inflammatory Bowel Diseases , 2018, Front. Immunol..
[31] J. T. Kuenstner,et al. Anti-microbial Antibodies, Host Immunity, and Autoimmune Disease , 2018, Front. Med..
[32] Mark D. Robinson,et al. Compensation of Signal Spillover in Suspension and Imaging Mass Cytometry , 2018, Cell systems.
[33] P. Klenerman,et al. Innate‐like CD8+ T‐cells and NK cells: converging functions and phenotypes , 2018, Immunology.
[34] C. Sina,et al. The intestinal complement system in inflammatory bowel disease: Shaping intestinal barrier function. , 2018, Seminars in immunology.
[35] STAT3 regulates cytotoxicity of human CD57+ CD4+ T cells in blood and lymphoid follicles , 2018, Scientific Reports.
[36] E. Smits,et al. CD56 in the Immune System: More Than a Marker for Cytotoxicity? , 2017, Front. Immunol..
[37] A. Pera,et al. Adaptive Memory of Human NK-like CD8+ T-Cells to Aging, and Viral and Tumor Antigens , 2016, Front. Immunol..
[38] Asha A. Nair,et al. The Role of the Histone Methyltransferase Enhancer of Zeste Homolog 2 (EZH2) in the Pathobiological Mechanisms Underlying Inflammatory Bowel Disease (IBD)* , 2016, The Journal of Biological Chemistry.
[39] A. Yoshimura,et al. Induced Regulatory T Cells: Their Development, Stability, and Applications. , 2016, Trends in immunology.
[40] A. Chauhan. Human CD4+ T-Cells: A Role for Low-Affinity Fc Receptors , 2016, Front. Immunol..
[41] H. Maecker,et al. Platinum‐conjugated antibodies for application in mass cytometry , 2016, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[42] D. Owczarek,et al. Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications. , 2016, World journal of gastroenterology.
[43] V. Kuchroo,et al. TIGIT predominantly regulates the immune response via regulatory T cells , 2024, The Journal of clinical investigation.
[44] Xin Yu,et al. Identification of a FOXP3+CD3+CD56+ population with immunosuppressive function in cancer tissues of human hepatocellular carcinoma , 2015, Scientific Reports.
[45] H. Maecker,et al. Barcoding of Live Human Peripheral Blood Mononuclear Cells for Multiplexed Mass Cytometry , 2015, The Journal of Immunology.
[46] H. Maecker,et al. Multiparameter Phenotyping of Human PBMCs Using Mass Cytometry. , 2015, Methods in molecular biology.
[47] Yufeng Shen,et al. Spatial Map of Human T Cell Compartmentalization and Maintenance over Decades of Life , 2014, Cell.
[48] A. Stadnyk,et al. The Complement System in Inflammatory Bowel Disease , 2014, Inflammatory bowel diseases.
[49] M. Huber,et al. IRF4 at the crossroads of effector T‐cell fate decision , 2014, European journal of immunology.
[50] P. Klenerman,et al. CD161++CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner , 2013, European journal of immunology.
[51] F. Sallusto,et al. The who's who of T‐cell differentiation: Human memory T‐cell subsets , 2013, European journal of immunology.
[52] G. Corazza,et al. The role of interleukin 17 in Crohn’s disease-associated intestinal fibrosis , 2013, Fibrogenesis & tissue repair.
[53] J. O’Shea,et al. Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease. , 2013, The Journal of allergy and clinical immunology.
[54] D. Bending,et al. CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines. , 2013, Blood.
[55] S. Nutt,et al. Differentiation and function of Foxp3(+) effector regulatory T cells. , 2013, Trends in immunology.
[56] P. Klenerman,et al. CD161-Expressing Human T Cells , 2011, Front. Immun..
[57] M. Vatn,et al. Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn's disease patients , 2011, Scandinavian journal of gastroenterology.
[58] F. Ghiringhelli,et al. Human FOXP3 and cancer , 2010, Oncogene.
[59] M. Neurath,et al. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression. , 2009, Gastroenterology.
[60] Erin E. Murphy,et al. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation , 2009, The Journal of experimental medicine.
[61] Keiichiro Suzuki,et al. Preferential Generation of Follicular B Helper T Cells from Foxp3+ T Cells in Gut Peyer's Patches , 2009, Science.
[62] Z. Sun,et al. The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut , 2009, Mucosal Immunology.
[63] H. Ljunggren,et al. Elevated Numbers of FcγRIIIA+ (CD16+) Effector CD8 T Cells with NK Cell-Like Function in Chronic Hepatitis C Virus Infection1 , 2008, The Journal of Immunology.
[64] H. Vié,et al. Effector memory alphabeta T lymphocytes can express FcgammaRIIIa and mediate antibody-dependent cellular cytotoxicity. , 2008, Journal of immunology.
[65] K. Papadakis,et al. Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease. , 2007, Clinical immunology.
[66] M. Neurath,et al. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue , 2007, Nature Protocols.
[67] T. Gingeras,et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells , 2006, The Journal of experimental medicine.
[68] T. Giese,et al. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. , 2005, Gastroenterology.
[69] Li Li,et al. Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.
[70] F. Ramsdell,et al. An essential role for Scurfin in CD4+CD25+ T regulatory cells , 2003, Nature Immunology.
[71] A. Rudensky,et al. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.
[72] T. Nomura,et al. Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .
[73] O. Mandelboim,et al. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[74] T. Mak,et al. The Transcription Factor Interferon Regulatory Factor 1 (IRF-1) Is Important during the Maturation of Natural Killer 1.1+ T Cell Receptor–α/β+ (NK1+ T) Cells, Natural Killer Cells, and Intestinal Intraepithelial T Cells , 1998, The Journal of experimental medicine.
[75] I. Leodolter. [Crohn's disease]. , 1967, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete.